254 related articles for article (PubMed ID: 30098670)
1. Oncologists' Views on Using Value to Guide Cancer Treatment Decisions.
Gidwani-Marszowski R; Nevedal AL; Blayney DW; Patel M; Kelly PA; Timko C; Ramchandran K; Murrell SS; Asch SM
Value Health; 2018 Aug; 21(8):931-937. PubMed ID: 30098670
[TBL] [Abstract][Full Text] [Related]
2. Oncologists' End of Life Treatment Decisions.
Bluhm M; Connell CM; Janz N; Bickel K; DeVries R; Silveira M
J Appl Gerontol; 2017 Apr; 36(4):416-440. PubMed ID: 26198272
[TBL] [Abstract][Full Text] [Related]
3. Oncologists' views on the importance of general practitioners for cancer patients: a qualitative interview study from Germany.
Engler J; Kone I; Holmberg C; Baumann W; Siebenhofer A; Güthlin C
Fam Pract; 2017 Nov; 34(6):730-734. PubMed ID: 28486693
[TBL] [Abstract][Full Text] [Related]
4. The Appropriate Provision of Primary versus Specialist Palliative Care to Cancer Patients: Oncologists' Perspectives.
Gidwani R; Nevedal A; Patel M; Blayney DW; Timko C; Ramchandran K; Kelly PA; Asch SM
J Palliat Med; 2017 Apr; 20(4):395-403. PubMed ID: 27997278
[TBL] [Abstract][Full Text] [Related]
5. Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey.
Schrag D; Hanger M
J Clin Oncol; 2007 Jan; 25(2):233-7. PubMed ID: 17210946
[TBL] [Abstract][Full Text] [Related]
6. Patients' and oncologists' views on how oncologists may best address patients' emotions during consultations: An interview study.
Visser LNC; Schepers S; Tollenaar MS; de Haes HCJM; Smets EMA
Patient Educ Couns; 2018 Jul; 101(7):1223-1231. PubMed ID: 29534845
[TBL] [Abstract][Full Text] [Related]
7. Oncologists' and Patients' Perceptions of Initial, Intermediate, and Final Goals of Care Conversations.
Schulman-Green D; Smith CB; Lin JJ; Feder S; Bickell NA
J Pain Symptom Manage; 2018 Mar; 55(3):890-896. PubMed ID: 29030209
[TBL] [Abstract][Full Text] [Related]
8. Shared decision making in oncology: A model based on patients', health care professionals', and researchers' views.
Bomhof-Roordink H; Fischer MJ; van Duijn-Bakker N; Baas-Thijssen MC; van der Weijden T; Stiggelbout AM; Pieterse AH
Psychooncology; 2019 Jan; 28(1):139-146. PubMed ID: 30346076
[TBL] [Abstract][Full Text] [Related]
9. The effect of priority setting decisions for new cancer drugs on medical oncologists' practice in Ontario: a qualitative study.
Berry SR; Hubay S; Soibelman H; Martin DK
BMC Health Serv Res; 2007 Nov; 7():193. PubMed ID: 18042302
[TBL] [Abstract][Full Text] [Related]
10. The value of personalizing medicine: medical oncologists' views on gene expression profiling in breast cancer treatment.
Bombard Y; Rozmovits L; Trudeau M; Leighl NB; Deal K; Marshall DA
Oncologist; 2015 Apr; 20(4):351-6. PubMed ID: 25746345
[TBL] [Abstract][Full Text] [Related]
11. The Role of Physicians in Rationing Cancer Care. Attitudes of German Oncologists.
Fernau S; Mehlis K; Schildmann J; Krause S; Winkler EC
Oncol Res Treat; 2017; 40(9):490-494. PubMed ID: 28813707
[TBL] [Abstract][Full Text] [Related]
12. Oncologists' Perceptions of Strategies for Discussing the Cost of Care with Cancer Patients and the Meaning of Those Conversations.
Scott AM; Harrington NG; Herman AA
Health Commun; 2024 Jun; 39(7):1343-1357. PubMed ID: 37190672
[TBL] [Abstract][Full Text] [Related]
13. Oncologists' Perceptions of Drug Affordability Using NCCN Evidence Blocks: Results from a National Survey.
Shah-Manek B; Wong W; Ravelo A; DiBonaventura M
J Manag Care Spec Pharm; 2018 Jun; 24(6):565-571. PubMed ID: 29451078
[TBL] [Abstract][Full Text] [Related]
14. What makes decision-making difficult for oncologists faced with critical situations? The socio-affective side of the physician-patient relationship.
Restivo L; Julian-Reynier C; Peyla L; Apostolidis T
J Health Psychol; 2020 Sep; 25(10-11):1396-1409. PubMed ID: 29417840
[TBL] [Abstract][Full Text] [Related]
15. Exploration of oncologists' attitudes toward and perceived value of patient-reported outcomes.
Meldahl ML; Acaster S; Hayes RP
Qual Life Res; 2013 May; 22(4):725-31. PubMed ID: 22684493
[TBL] [Abstract][Full Text] [Related]
16. Paradox of Prescribing Late Chemotherapy: Oncologists Explain.
Bluhm M; Connell CM; De Vries RG; Janz NK; Bickel KE; Silveira MJ
J Oncol Pract; 2016 Dec; 12(12):e1006-e1015. PubMed ID: 27650843
[TBL] [Abstract][Full Text] [Related]
17. What Is Important When Making Treatment Decisions in Metastatic Breast Cancer? A Qualitative Analysis of Decision-Making in Patients and Oncologists.
Rocque GB; Rasool A; Williams BR; Wallace AS; Niranjan SJ; Halilova KI; Turkman YE; Ingram SA; Williams CP; Forero-Torres A; Smith T; Bhatia S; Knight SJ
Oncologist; 2019 Oct; 24(10):1313-1321. PubMed ID: 30872466
[TBL] [Abstract][Full Text] [Related]
18. How long and how well: oncologists' attitudes toward the relative value of life-prolonging v. quality of life-enhancing treatments.
Kozminski MA; Neumann PJ; Nadler ES; Jankovic A; Ubel PA
Med Decis Making; 2011; 31(3):380-5. PubMed ID: 21088130
[TBL] [Abstract][Full Text] [Related]
19. Decision making in pediatric oncology: Views of parents and physicians in two European countries.
Badarau DO; Ruhe K; Kühne T; De Clercq E; Colita A; Elger BS; Wangmo T
AJOB Empir Bioeth; 2017; 8(1):21-31. PubMed ID: 28949870
[TBL] [Abstract][Full Text] [Related]
20. Qualitative analysis of practicing oncologists' attitudes and experiences regarding collection of patient-reported outcomes.
Jagsi R; Chiang A; Polite BN; Medeiros BC; McNiff K; Abernethy AP; Zon R; Loehrer PJ
J Oncol Pract; 2013 Nov; 9(6):e290-7. PubMed ID: 23943890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
